ReviewCardio-oncology (London, England)2025

Dexrazoxane makes doxorubicin-induced heart failure a rare event in sarcoma patients receiving high cumulative doses.

Haoyi Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.